CuminUP60® is a clinically validated, self-affirmed GRAS curcumin complex built on patented CGSF® co-grinding technology — engineered for high loading, 14× bioavailability and water dispersibility in functional foods, beverages and supplements.
As a long-recognized superstar of the health-care industry, curcumin's benefits are well known to the public. Yet poor solubility in water, instability at physiological and alkaline pH, and rapid metabolism result in low oral bioavailability — and limit how far the ingredient can go in real products.
Many manufacturers have raised curcumin's oral bioavailability to a degree, but complex production processes remain common technical shortcomings. When we list several doubts about curcumin products in recent years, four questions keep coming back.
Is the actual curcumin loading consistent with the product description?
Can the supplement be reasonably digested and absorbed after entering the human body?
Can poor solubility in water be solved?
Can it achieve significant health effects?
Focusing on these problems and technical difficulties, Chenland comprehensively upgraded potent curcumin — refreshing the application guidelines of the ingredient.
CuminUP60® combines min. 95% (HPLC) natural curcumin with Poloxamer 407 through a patented, solvent-free co-grinding process — yielding a water-dispersible curcumin complex standardized to 60% total curcuminoids.
Regional differences in bioactive concentration were investigated to control raw-material quality. The extract is built on 95% pure natural curcumin and complies with international limits for pesticides, heavy metals, PAHs, mycotoxins and bacterial counts.
Per the UV method for total curcumin: solubility of 95% curcumin raw material is 0.76 μg/ml, while CuminUP60® reaches 65.11 μg/ml — forming a homogeneous suspension upon contact with water.
Our professional team developed the CGSF® co-grinding, solvent-free extraction process to improve bioavailability and increase the water solubility of curcumin.
CuminUP60® was developed after careful evaluation of safety and efficacy through preclinical and clinical studies — including a Phase 1 trial with no reported adverse effects.
CuminUP60® forms a homogeneous suspension on contact with water — a step change in solubility versus standard 95% curcumin and typical commercial references.
Two single-center, randomized, crossover clinical trials in healthy adults, a Phase 1 safety study, and a comprehensive preclinical program — built on 60% curcuminoids, one small daily dose.
Outcome: CuminUP60® shows a total bioavailability 14× higher than that of standard curcumin and its conjugates in the reference product.
Outcome: Free curcumin in plasma increased by 306%, with a slow-release profile that prolonged time to peak concentration by 300% — with good safety and tolerability.
Safety evaluation of the novel curcumin complex CuminUP60® reported no adverse effects. The GRAS dossier further supports safety with repeat-dose 28-day oral toxicity and mutagenicity / genotoxicity studies.
A water-dispersible, clinically validated curcumin complex with broad health-benefit coverage — from cognitive function and immunity to joint support, respiratory wellness, energy and antioxidant defense.
| Product | Recommended Dose | × Potency | = Curcumin Content | Bioavailability | Curcumin Equivalence |
|---|---|---|---|---|---|
| CuminUP60® | 200 mg | 60% | 120 mg | 14× | 1680 mg |
| Regular 95% Curcumin | 1,000 mg | 95% | 950 mg | 1× | 950 mg |
When your product's performance matters, compromise isn't an option.
| Feature | CuminUP60® | Regular 95% Curcumin |
|---|---|---|
| Human clinical validation | 2 crossover trials + Phase 1 safety | Often none or borrowed data |
| Bioavailability | 14× (clinically measured) | 1× |
| Water solubility | 65.11 μg/ml — homogeneous suspension | 0.76 μg/ml — poor dispersion |
| Standardization | 60% total curcuminoids, HPLC verified | 95% curcumin, limited standardization |
| Regulatory status | Self-affirmed GRAS + FDA SFC notified | Varies by source |
| Formulation flexibility | Capsules · tablets · liquid · drink mix · gummies | Limited by poor dispersibility |
Produced under FDA Current Good Manufacturing Practices (cGMP), independently evaluated for GRAS status by an expert panel, and certified across global quality standards.
Manufacturing facility — FDA Current Good Manufacturing Practices
Independent GRAS Associates expert panel · 68-page dossier · 15–230 mg/serving in foods & beverages
Three Structure/Function Claim notifications on file
GMO and irradiation status verified in the GRAS dossier
Halal certified
Kosher certified
Vegan · gluten-free product profile
Third-party tested for major U.S. food allergens
Water-dispersible by design, CuminUP60® slots into the formats consumers reach for every day.
